Intestinal permeability in patients undergoing stem cell transplantation correlates with systemic acute phase responses and dysbiosis. Blood Advances. 2023; 7:5137-5151.
.Gut Microbiome Composition Is Associated With Future Onset of Crohn's Disease in Healthy First-Degree Relatives. Gastroenterology. 2023; 165:670-681.
.Racial Disparities in Pediatric Inflammatory Bowel Disease Care: Differences in Outcomes and Health Service Utilization Between Black and White Children. The Journal of Pediatrics. 2023; 260:113522.
.Mucosal transcriptomics highlight lncRNAs implicated in ulcerative colitis, Crohn's disease, and celiac disease. JCI insight. 2023; 8:e170181.
.The microbiome in adolescents with irritable bowel syndrome and changes with percutaneous electrical nerve field stimulation. Neurogastroenterology and Motility. 2023; 35:e14573.
.Transcriptome analysis in acute gastrointestinal graft-versus host disease reveals a unique signature in children and shared biology with pediatric inflammatory bowel disease. Haematologica: the hematology journal. 2023; 108:1803-1816.
.GATA6-AS1 Regulates Intestinal Epithelial Mitochondrial Functions, and its Reduced Expression is Linked to Intestinal Inflammation and Less Favourable Disease Course in Ulcerative Colitis. Journal of Crohn's and Colitis. 2023; 17:960-971.
.2023; 164:s-703.
. Su1884 ACUTE PANCREATITIS IS ASSOCIATED WITH GUT DYSBIOSIS IN CHILDREN. Gastroenterology.2023; 164:s-504-s-505.
. Su1013 EVALUATION OF INSURANCE TYPE ON PRIOR AUTHORIZATION (PA) DELAYS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS PRESCRIBED BIOLOGIC THERAPIES. Gastroenterology.2023; 164:s-170.
. 783 DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAÏVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS. Gastroenterology.2023; 164:s-132-s-133.
. 675 EICOSATETRAYNOIC ACID REGULATES PRO-FIBROTIC PATHWAYS IN AN INDUCED PLURIPOTENT STEM CELL DERIVED MACROPHAGE:HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN'S DISEASE. Gastroenterology.Multicenter Cohort Study of Infliximab Pharmacokinetics and Therapy Response in Pediatric Acute Severe Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 2023; 21:1338-1347.
.Genetic architecture of the inflammatory bowel diseases across East Asian and European ancestries. Nature Genetics. 2023; 55:796-806.
.2023; 164:s97-s98.
. EICOSATETRAYNOIC ACID REGULATES PRO-FIBROTIC PATHWAYS IN AN INDUCED PLURIPOTENT STEM CELL DERIVED MACROPHAGE:HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Gastroenterology.2023; 164:s72-s73.
. DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAÏVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS. Gastroenterology.Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance. Alimentary Pharmacology and Therapeutics. 2023; 57:524-539.
.Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2023; 29:286-296.
.Environmental Interaction of Resolved Human Cytomegalovirus Infection With Crohn's Disease Location. Inflammatory Bowel Diseases. 2023; 29:328-331.
.2023; 29:s56-s57.
. DEVELOPMENT OF AN OPTIMAL MACHINE LEARNING MODEL USING TREATMENT NAÏVE DIAGNOSTIC PATHOLOGY IMAGES TO PREDICT STEROID-FREE CLINICAL REMISSION AT ONE YEAR IN PEDIATRIC ULCERATIVE COLITIS. Inflammatory Bowel Diseases.2023; 29:s76-s77.
. EICOSATETRAYNOIC ACID REGULATES PRO-FIBROTIC PATHWAYS IN AN INDUCED PLURIPOTENT STEM CELL DERIVED MACROPHAGE:HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Inflammatory Bowel Diseases.Mucosal microbiome is predictive of pediatric Crohn's disease across geographic regions in North America. F1000Research. 2023; 11:156.
.Ultrasound shear wave elastography in pediatric stricturing small bowel Crohn disease: correlation with histology and second harmonic imaging microscopy. Pediatric Radiology: roentgenology, nuclear medicine, ultrasonics, CT, MRI. 2023; 53:34-45.
.Digital Therapeutic Self-Management Intervention in Adolescents With Inflammatory Bowel Disease. Journal of Pediatric Gastroenterology and Nutrition. 2023; 76:38-42.
.The Simplified MR Index of Activity Score in Pediatric Small-Bowel Crohn Disease: An Interreader Agreement and Responsiveness Study. American Journal of Roentgenology. 2023; 220:126-133.
.Meta-analysis defines predominant shared microbial responses in various diseases and a specific inflammatory bowel disease signal. Genome Biology: biology for the post-genomic era. 2022; 23:61.
.Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis. Journal of Crohn's and Colitis. 2022; 16:1735-1750.
.Human intestinal myofibroblasts deposited collagen VI enhances adhesiveness for T cells - A novel mechanism for maintenance of intestinal inflammation. Matrix Biology. 2022; 113:1-21.
.Nutritional deficiency in an intestine-on-a-chip recapitulates injury hallmarks associated with environmental enteric dysfunction. Nature Biomedical Engineering. 2022; 6:1236-1247.
.MRI-Based Characterization of Intestinal Motility in Children and Young Adults With Newly Diagnosed Ileal Crohn Disease Treated by Biologic Therapy: A Controlled Prospective Study. American Journal of Roentgenology. 2022; 219:655-664.
.Bowel wall MRI T1 relaxation estimates for assessment of intestinal inflammation in pediatric Crohn's disease. Abdominal Radiology. 2022; 47:2730-2738.
.Eicosatetraynoic Acid and Butyrate Regulate Human Intestinal Organoid Mitochondrial and Extracellular Matrix Pathways Implicated in Crohn's Disease Strictures. Inflammatory Bowel Diseases. 2022; 28:988-1003.
.Velocity-Encoded Phase-Contrast MRI for Measuring Mesenteric Blood Flow in Patients With Newly Diagnosed Small-Bowel Crohn Disease. American Journal of Roentgenology. 2022; 219:132-141.
.Decision making about anti-TNF therapy: A pilot trial of a shared decision-making intervention. Patient Education and Counseling. 2022; 105:1075-1081.
.2022; 162:s-428-s-429.
. Sa1590: RADIOGRAPHIC PROGRESSION AND THE EFFECT OF ANTI-TUMOR NECROSIS FACTOR IN CHILDREN WITH TREATMENT NAÏVE CROHN'S DISEASE. Gastroenterology.Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study. Gastroenterology. 2022; 162:1635-1649.
.Methylation quantitative trait loci are largely consistent across disease states in Crohn's disease. Editor, Myers C. G3-Genes Genomes Genetics. 2022; 12:jkac041.
.Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease. Alimentary Pharmacology and Therapeutics. 2022; 55:593-603.
.Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis. Inflammatory Bowel Diseases. 2022; 28:151-160.
.2022; 162:s100.
. REAL-WORLD VEDOLIZUMAB PHARMACOKINETIC STUDY IN CHILDREN IDENTIFIES TWO NOVEL BIOMARKERS OF DRUG CLEARANCE. Gastroenterology.2022; 162:s62-s63.
. EICOSATETRAYNOIC ACID REGULATES MITOCHONDRIAL AND EXTRA-CELLULAR MATRIX GENE EXPRESSION AND TISSUE STIFFNESS IN A HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Gastroenterology.2022; 162:s49-s50.
. ILEAL ENTEROCYTE BRUSH BORDER ABNORMALITIES ASSOCIATE WITH PROGRESSIVE DISEASE COURSE IN PEDIATRICS CROHN’S DISEASE. Gastroenterology.2022; 28:s100.
. REAL-WORLD VEDOLIZUMAB PHARMACOKINETIC STUDY IN CHILDREN IDENTIFIES TWO NOVEL BIOMARKERS OF DRUG CLEARANCE. Inflammatory Bowel Diseases.2022; 28:s62-s63.
. EICOSATETRAYNOIC ACID REGULATES MITOCHONDRIAL AND EXTRA-CELLULAR MATRIX GENE EXPRESSION AND TISSUE STIFFNESS IN A HUMAN INTESTINAL ORGANOID MODEL OF ILEAL CROHN’S DISEASE. Inflammatory Bowel Diseases.Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative Colitis. Journal of Pediatric Gastroenterology and Nutrition. 2022; 74:72-78.
.Bile Acid Profiling Reveals Distinct Signatures in Undernourished Children with Environmental Enteric Dysfunction. The Journal of nutrition. 2021; 151:3689-3700.
.Predicting disease course in ulcerative colitis using stool proteins identified through an aptamer-based screen. Nature Communications. 2021; 12:3989.
.Elevated fecal calprotectin is linked to psychosocial complexity in pediatric functional abdominal pain disorders. BMC Research Notes. 2021; 14:360.
.Profiling non-coding RNA levels with clinical classifiers in pediatric Crohn's disease. BMC Medical Genomics. 2021; 14:194.
.Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease. Inflammatory Bowel Diseases. 2021; 27:1707-1718.
.Stratification of risk of progression to colectomy in ulcerative colitis via measured and predicted gene expression. The American Journal of Human Genetics. 2021; 108:1765-1779.
.Application of mucosal functional genomics to childhood undernutrition and stunting: Insights into mechanisms and targeted interventions. EBioMedicine. 2021; 71:103553.
.Achieving Target Infliximab Drug Concentrations Improves Blood and Fecal Neutrophil Biomarkers in Crohn's Disease. Inflammatory Bowel Diseases. 2021; 27:1045-1051.
.Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's Disease. Clinical Pharmacology and Therapeutics. 2021; 109:1639-1647.
.Deconvolution of monocyte responses in inflammatory bowel disease reveals an IL-1 cytokine network that regulates IL-23 in genetic and acquired IL-10 resistance. Gut. 2021; 70:1023-1036.
.2021; 15:s030.
. OP32 Stool microbiome communities predict remission in treatment-naïve Pediatric Crohn’s Disease patients. Journal of Crohn's and Colitis.Quality Improvement Methodology Optimizes Infliximab Levels in Pediatric Patients with Inflammatory Bowel Disease. Pediatric Quality and Safety. 2021; 6:e400.
.DUOX2 variants associate with preclinical disturbances in microbiota-immune homeostasis and increased inflammatory bowel disease risk. The Journal of Clinical Investigation. 2021; 131:141676.
.Mucosal Genomics Implicate Lymphocyte Activation and Lipid Metabolism in Refractory Environmental Enteric Dysfunction. Gastroenterology. 2021; 160:2055-2071.e0.
.2021; 160:s-615.
. Su094 IMMUNE AND METABOLIC PATHOGENESIS OF ENVIRONMENTAL ENTERIC DYSFUNCTION IN CHILDHOOD UNDERNUTRITION: A BIRTH INCEPTION COHORT. Gastroenterology.2021; 160:s-145-s-146.
. 728 PLASMA PROTEOMIC RESPONSE SIGNATURE FOR CHILDREN RECEIVING INFLIXIMAB FOR CROHN'S DISEASE. Gastroenterology.2021; 160:s-145.
. 727 ANTI-TNF PHARMACOKINETICS AND RESPONSE TO THERAPY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (THE ARCH STUDY). Gastroenterology.Effect of a Practice-wide Anti-TNF Proactive Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 2021; 27:482-492.
.Colonic Epithelial-Derived Selenoprotein P Is the Source for Antioxidant-Mediated Protection in Colitis-Associated Cancer. Gastroenterology. 2021; 160:1694-1708.e3.
.Whole-genome sequencing of African Americans implicates differential genetic architecture in inflammatory bowel disease. The American Journal of Human Genetics. 2021; 108:431-445.
.2021; 160:s75-s76.
. ANTI-TNF PHARMACOKINETICS AND RESPONSE TO THERAPY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (THE ARCH STUDY). Gastroenterology.Altered Intestinal ACE2 Levels Are Associated With Inflammation, Severe Disease, and Response to Anti-Cytokine Therapy in Inflammatory Bowel Disease. Gastroenterology. 2021; 160:809-822.e7.
.Mucosal Inflammatory and Wound Healing Gene Programs Reveal Targets for Stricturing Behavior in Pediatric Crohn's Disease. Journal of Crohn's and Colitis. 2021; 15:273-286.
.2021; 27:s55-s56.
. ANTI-TNF PHARMACOKINETICS AND RESPONSE TO THERAPY IN PEDIATRIC ACUTE SEVERE ULCERATIVE COLITIS (THE ARCH STUDY). Inflammatory Bowel Diseases.Transition to Adult IBD Care: A Pilot Multi-Site, Telehealth Hybrid Intervention. Journal of Pediatric Psychology. 2021; 46:1-11.
.Ileal Derived Organoids From Crohn's Disease Patients Show Unique Transcriptomic and Secretomic Signatures. CMGH Cellular and Molecular Gastroenterology and Hepatology. 2021; 12:1267-1280.
.Machine learning identifies novel blood protein predictors of penetrating and stricturing complications in newly diagnosed paediatric Crohn's disease. Alimentary Pharmacology and Therapeutics. 2021; 53:281-290.
.PIR-B Regulates CD4+ IL17a+ T-Cell Survival and Restricts T-Cell-Dependent Intestinal Inflammatory Responses. CMGH Cellular and Molecular Gastroenterology and Hepatology. 2021; 12:1479-1502.
.2020; 00:1-6.
. Hierarchical Deep Convolutional Neural Networks for Multi-category Diagnosis of Gastrointestinal Disorders on Histopathological Images. 2020 IEEE International Conference on Healthcare Informatics (ICHI).Serum Matrix Metalloproteinase 7 Is a Diagnostic Biomarker of Biliary Injury and Fibrosis in Pediatric Autoimmune Liver Disease. Hepatology Communications. 2020; 4:1680-1693.
.Microbiota-derived metabolite promotes HDAC3 activity in the gut. Nature. 2020; 586:108-112.
.Drug induced pancreatitis is the leading known cause of first attack acute pancreatitis in children. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2020; 20:1103-1108.
.Analysis of Using the Total White Blood Cell Count to Define Severe New-onset Ulcerative Colitis in Children. Journal of Pediatric Gastroenterology and Nutrition. 2020; 71:354-360.
.A Micro-longitudinal Approach to Measuring Medication Adherence in Pediatric Inflammatory Bowel Diseases. Journal of Pediatric Gastroenterology and Nutrition. 2020; 71:366-370.
.Microbial Shifts and Shorter Time to Bowel Resection Surgery Associated with C. difficile in Pediatric Crohn's Disease. Inflammatory Bowel Diseases. 2020; 26:1212-1221.
.2020; 158:s-234-s-235.
. 1162 BASELINE ILEAL LUMINAL NARROWING IS ASSOCIATED WITH SPECIFIC PRE-TREATMENT MUCOSAL GENE PROGRAMS AND MICROBIAL SHIFTS AND SUBSEQUENT LIKELIHOOD OF TRANSMURAL HEALING IN PEDIATRIC CROHN'S DISEASE. Gastroenterology.2020; 158:s-233-s-234.
. 1160 REAL-WORLD PEDIATRIC INFLIXIMAB PHARMACOKINETIC MODEL VERIFIES CRITICAL NEED FOR PRECISION DOSING SOFTWARE. Gastroenterology.2020; 158:s-130-s-131.
. 613 ANTIBODIES TO INFLIXIMAB ACCELERATE DRUG CLEARANCE WHILE INTENSIFICATION STRATEGIES REVERSE IMMUNOGENICITY AND RECAPTURE CLINICAL RESPONSE. Gastroenterology.2020; 158:s-187-s-188.
. 935 PRE-TREATMENT MUCOSAL INFLAMMATORY AND WOUND HEALING GENE PROGRAMS REVEAL MECHANISMS ASSOCIATED WITH FUTURE STRICTURING BEHAVIOR DURING FIVE YEAR FOLLOW-UP IN PEDIATRIC CROHN'S DISEASE. Gastroenterology.Reduced expression of COVID-19 host receptor, ACE2 is associated with small bowel inflammation, more severe disease, and response to anti-TNF therapy in Crohn's disease. 2020; 1:2020.04.19.20070995.
.Recommendations for Successful Transition of Adolescents With Inflammatory Bowel Diseases to Adult Care. Clinical Gastroenterology and Hepatology. 2020; 18:276-289.e2.
.2020; 14:s006.
. OP06 Comparison between Crohn and coeliac diseases small intestine transcriptomics and microbial data define similarities and divergent pathways linked to pathogenesis. Journal of Crohn's and Colitis.2020; 14:s127.
. DOP89 Pre-treatment mucosal inflammatory and wound healing gene programmes reveal mechanisms associated with future stricturing behaviour during 5-year follow-up in paediatric Crohn’s disease. Journal of Crohn's and Colitis.Mitochondrial Networks: A New Therapeutic Target in Colitis. CMGH Cellular and Molecular Gastroenterology and Hepatology. 2020; 10:426-427.
.Study of Environmental Enteropathy and Malnutrition (SEEM) in Pakistan: protocols for biopsy based biomarker discovery and validation. BMC Pediatrics. 2019; 19:247.
.Defining the Celiac Disease Transcriptome using Clinical Pathology Specimens Reveals Biologic Pathways and Supports Diagnosis. Scientific Reports. 2019; 9:16163.
.Shared decision making in IBD: A novel approach to trial consent and timing. Contemporary Clinical Trials Communications. 2019; 16:100447.
.Neutrophil GM-CSF signaling in inflammatory bowel disease patients is influenced by non-coding genetic variants. Scientific Reports. 2019; 9:9168.
.Evaluation of a Novel Educational Tool in Adolescents With Inflammatory Bowel Disease: The NEAT Study. Journal of Pediatric Gastroenterology and Nutrition. 2019; 69:564-569.
.Serologic, but Not Genetic, Markers Are Associated With Impaired Anthropometrics at Diagnosis of Pediatric Crohn's Disease. Journal of Pediatric Gastroenterology and Nutrition. 2019; 69:e129-e134.
.Longitudinal non-adherence predicts treatment escalation in paediatric ulcerative colitis. Alimentary Pharmacology and Therapeutics. 2019; 50:911-918.
.Elevated Pretreatment Plasma Oncostatin M Is Associated With Poor Biochemical Response to Infliximab. Crohn's && Colitis 360. 2019; 1:otz026.
.Characterization of Stool Virome in Children Newly Diagnosed With Moderate to Severe Ulcerative Colitis. Inflammatory Bowel Diseases. 2019; 25:1656-1662.
.Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019; 178:1493-1508.e20.
.Prioritizing Crohn's disease genes by integrating association signals with gene expression implicates monocyte subsets. Genes and Immunity. 2019; 20:577-588.
.Association Between Plasma Level of Collagen Type III Alpha 1 Chain and Development of Strictures in Pediatric Patients With Crohn's Disease. Clinical Gastroenterology and Hepatology. 2019; 17:1799-1806.
.Improving IBD Transition, Self-management, and Disease Outcomes With an In-clinic Transition Coordinator. Journal of Pediatric Gastroenterology and Nutrition. 2019; 69:194-199.
.Variation in Care in the Management of Children With Crohn's Disease: Data From a Multicenter Inception Cohort Study. Inflammatory Bowel Diseases. 2019; 25:1208-1217.
.Early Onset Granulomatous Colitis Associated with a Mutation in NCF4 Resolved with Hematopoietic Stem Cell Transplantation. The Journal of Pediatrics. 2019; 210:220-225.
.Development of Infliximab Target Concentrations During Induction in Pediatric Crohn Disease Patients. Journal of Pediatric Gastroenterology and Nutrition. 2019; 69:68-74.
.Challenges in IBD Research: Precision Medicine. Inflammatory Bowel Diseases. 2019; 25:S31-S39.
.Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation. Gastroenterology. 2019; 156:2254-2265.e3.
.Genetic variants in acute, acute recurrent and chronic pancreatitis affect the progression of disease in children. Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 2019; 19:535-540.
.Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019; 569:655-662.
.2019; 156:s-60.
. 303 – Effect of a Practice-Wide Anti-TNF Therapeutic Drug Monitoring Program on Outcomes in Pediatric Patients with Inflammatory Bowel Disease. Gastroenterology.Serum Protein Biomarkers of Fibrosis Aid in Risk Stratification of Future Stricturing Complications in Pediatric Crohn's Disease. The American Journal of Gastroenterology (Elsevier). 2019; 114:777-785.
.2019; 156:s-392.
. Sa1762 – Large-Scale Proteomics Identifies Anti-TNF Response Signature. Gastroenterology.2019; 156:s-613.
. Su1792 – Elevation of Plasma Oncostatin M is Associated with Primary Biochemical Nonresponse and Secondary Clinical Nonresponse to Infliximab in Pediatric Crohn’s Disease Patients. Gastroenterology.2019; 156:s-200.
. 882 – Normalization of Fecal Calprotectin Requires Higher Trough Infliximab Levels in Children with Inflammatory Bowel Disease. Gastroenterology.2019; 156:s-44.
. 235 – Early Infliximab Pharmacokinetics and Week One Clinical Response in Pediatric Acute Severe Ulcerative Colitis: the Arch Study. Gastroenterology.Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study. The Lancet. 2019; 393:1708-1720.
.Content and Usability Evaluation of Medication Adherence Mobile Applications for Use in Pediatrics. Journal of Pediatric Psychology. 2019; 44:333-342.
.Constitutive STAT5 activation regulates Paneth and Paneth-like cells to control Clostridium difficile colitis. Life Science Alliance. 2019; 2:e201900296.
.Genetic and Transcriptomic Variation Linked to Neutrophil Granulocyte-Macrophage Colony-Stimulating Factor Signaling in Pediatric Crohn's Disease. Inflammatory Bowel Diseases. 2019; 25:547-560.
.Age-of-diagnosis dependent ileal immune intensification and reduced alpha-defensin in older versus younger pediatric Crohn Disease patients despite already established dysbiosis. Mucosal Immunology. 2019; 12:491-502.
.2019; 25:s54.
. 30 ELEVATION OF PLASMA ONCOSTATIN M IS ASSOCIATED WITH PRIMARY BIOCHEMICAL NONRESPONSE AND SECONDARY CLINICAL NONRESPONSE TO INFLIXIMAB IN PEDIATRIC CROHN’S DISEASE PATIENTS. Inflammatory Bowel Diseases.Genetic variants and pathways implicated in a pediatric inflammatory bowel disease cohort. Genes and Immunity. 2019; 20:131-142.
.2019; 156:s76-s77.
. 30 ELEVATION OF PLASMA ONCOSTATIN M IS ASSOCIATED WITH PRIMARY BIOCHEMICAL NONRESPONSE AND SECONDARY CLINICAL NONRESPONSE TO INFLIXIMAB IN PEDIATRIC CROHN’S DISEASE PATIENTS. Gastroenterology.Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD. Inflammatory Bowel Diseases. 2019; 25:27-32.
.Rapid Progression of Acute Pancreatitis to Acute Recurrent Pancreatitis in Children. Journal of Pediatric Gastroenterology and Nutrition. 2019; 68:104-109.
.
Lee Denson, MD
Associate Professor
UC Department of Pediatrics
Mailing Address:
Division of Gastroenterology, Hepatology and Nutrition
3333 Burnet Ave.
MLC 2010
Cincinnati, OH 45229-3039
Phone: 513-636-7575
Fax: 513-636-5581
Email: lee.denson@cchmc.org